According to the RNA-seq data used by GEPIA (https://gepia.cancer-pku.cn), the RNA modification proteins YTHDC1/2, HNRNPCA2B1, IGF2BP2/3 and YBX1 were significantly highly expressed and only METTL3/16 expressed at low levels in ovarian cancer tissues; other regulatory enzymes were not significantly differentially expressed. The gene discussed is IGF2BP2; the disease is ovarian carcinoma.